生物膜启发的脂质纳米粒子增强了血友病A的CRISPR-Cas9编辑
Juan-Juan Zhao1, Sai-Ning Tian2, Zu-Yi Peng2
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; Tianjin Institutes of Health Science, Tianjin 301600, China.
概括
新的生物膜启发的脂质纳米粒子 (LNP) 增强了CRISPR-Cas9基因编辑疗法. 这些工程LNP提高了肝脏向和体内编辑效率,为病毒载体提供了更安全的替代方案.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 脂质纳米颗粒 (LNP) 对于RNA疗法至关重要,但在CRISPR-Cas9传递方面面临挑战,包括缺陷的内体逃生和免疫激活.
- 现有的传递方法,如腺相关病毒 (AAV) 载体,具有插入性突变发生的风险.
研究的目的:
- 为改进向肝脏的CRISPR-Cas9传递设计新的生物膜启发的LNP.
- 在A型血友病小鼠模型中,与现有方法相比,评估这些LNP的疗效和安全性.
主要方法:
- 以生物膜为灵感的LNP的配方,包括基米林和C18-银酸胺.
- 在体内评估LNP介导的CRISPR-Cas9编辑效率,并与基准ALC-0315 LNP和AAV矢量进行比较.
- 在A型血友病小鼠模型中评估基因校正耐用性,免疫反应,非目标效应和毒性.
主要成果:
- 与基准LNP相比,优化的LNP在体内编辑效率增加了2.3倍.
- 与AAV载体相比,通过LNP传递的CRISPR-Cas9显示免疫激活减少,没有插入性突变发生.
- 在A型血友病小鼠中,单次LNP剂量在12周以上的时间内实现了持续的VIII因子活性 (>50%的野生类型),具有最小的毒性和非目标效应.
- 在长时间储存和冷-解周期后,LNP保持了稳定性和编辑效力.
结论:
- 生物膜启发的LNP代表了CRISPR-Cas9传递的安全有效的非病毒平台,克服了当前方法的局限性.
- 这些LNP显示出针对肝脏的基因编辑疗法的巨大潜力,包括对血友病A等遗传疾病的持久纠正.
- 这些LNP的稳定性和易用性支持它们在基因编辑治疗中的翻译适用性.
相关概念视频
CRISPR/Cas9 Genome Editing
213
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
213
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K
Homologous Recombination
51.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
51.7K


